Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Myelodysplastic Syndromes
•
Rheumatology
•
Hematology
•
General Rheumatology
•
Relapsing polychondritis
•
Dermatology
•
VEXAS
In older male patients with a history of underlying autoimmune disease, what clinical manifestations would prompt you to evaluate for VEXAS Syndrome?
Related Questions
What is your approach to evaluation in patients who present with erythromelalgia?
When would you consider using G-CSF in patients with rheumatic disease who have received cyclophosphamide?
What approaches can we take to initiate therapy and improve survival rates in patients with HLH?
What is your approach to management of chronic neutropenia in a patient with Sjogren’s who was recently diagnosed with metastatic endometrial cancer and plans to start chemotherapy?
What is your approach to evaluating a patient with known rheumatologic disease and elevated free kappa:lambda ratio, but no evidence of monoclonal immunoglobulins?
What is your approach to RSV vaccination in immunocompromised patients?
How do you approach work up for underlying rheumatologic disease in patients referred for chronic urticaria?
How do you approach treatment of SAPHO syndrome?
Have you seen drug induced SCLE from IL-17 inhibitors?
How would approach the management of a patient with significantly positive anticardiolopin and beta 2 glycoprotein antibodies in the absence of any clotting (including obstetric) history but with significant thrombocytopenia (but no other features of active connective tissue disease)?